1. Home
  2. SHO vs PTGX Comparison

SHO vs PTGX Comparison

Compare SHO & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

HOLD

Current Price

$12.61

Market Cap

2.0B

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$139.63

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHO
PTGX
Founded
1995
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
9.3B
IPO Year
2004
2016

Fundamental Metrics

Financial Performance
Metric
SHO
PTGX
Price
$12.61
$139.63
Analyst Decision
Buy
Strong Buy
Analyst Count
12
14
Target Price
$12.04
★ $178.21
AVG Volume (30 Days)
★ 2.5M
712.4K
Earning Date
11-06-2026
11-05-2026
Dividend Yield
★ 2.85%
N/A
EPS Growth
★ N/A
N/A
EPS
0.22
★ 2.35
Revenue
★ $1,115,167,000.00
N/A
Revenue This Year
$2.49
$1,077.07
Revenue Next Year
N/A
N/A
P/E Ratio
★ $57.23
$58.87
Revenue Growth
N/A
★ N/A
52 Week Low
$8.69
$73.84
52 Week High
$12.78
$160.81

Technical Indicators

Market Signals
Indicator
SHO
PTGX
Relative Strength Index (RSI) 80.34 49.64
Support Level $10.95 $131.54
Resistance Level N/A $142.20
Average True Range (ATR) 0.31 6.13
MACD 0.13 0.07
Stochastic Oscillator 91.42 51.17

Price Performance

Historical Comparison
SHO
PTGX

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: